INCY Incyte Corp.
Incyte Corp. (INCY) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $3.2M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| CAGNONI PABLO J | President, Global Head of R&D | Sell | 10,801 | $125.56 | $1.4M | 183,200 −5.6% of holding | |
| CAGNONI PABLO J | President, Global Head of R&D | Sell | 10,803 | $120.04 | $1.3M | 194,001 −5.3% of holding | |
| CAGNONI PABLO J | President, Global Head of R&D | Sell | 10,640 | $122.69 | $1.3M | 204,804 −4.9% of holding | |
| Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2,207 | $123.99 | $273.6K | 61,441 −3.5% of holding | |
| Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 6,055 | $120.43 | $729.2K | 61,441 −9% of holding | |
| Mayes Patrick A 11 fills | EVP & Chief Scientific Officer | Sell | 41,899 | $119.46 | $5.0M | 88,679 −32.1% of holding | |
| CAGNONI PABLO J | President, Global Head of R&D | Sell | 15,888 | $119.70 | $1.9M | 215,444 −6.9% of holding | |
| Stein Steven H | CMO & Head of Late-Stage Dev. | Sell | 1,877 | $114.73 | $215.3K | 21,118 −8.2% of holding | |
| Issa Mohamed Khairie | EVP, Head of U.S. Commercial | Sell | 1,093 | $115.01 | $125.7K | 63,940 −1.7% of holding | |
| Stein Steven H | CMO & Head of Late-Stage Dev. | Sell | 28,237 | $113.05 | $3.2M | 26,083 −52% of holding | |
| Tray Thomas | Principal Accounting Officer | Sell | 2,639 | $100.00 | $263.9K | 21,132 −11.1% of holding | |
| Tray Thomas | Principal Accounting Officer | Sell | 2,051 | $97.35 | $199.7K | 21,132 −8.8% of holding | |
| Clancy Paul J | Director | Sell | 15,000 | $94.93 | $1.4M | 23,741 −38.7% of holding | |
| CAGNONI PABLO J | President, Global Head of R&D | Sell | 18,667 | $96.50 | $1.8M | 262,692 −6.6% of holding | |
| CAGNONI PABLO J | President, R&D | Sell | 18,667 | $94.24 | $1.8M | 234,800 −7.4% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.